Back to Basics: How COVID-19 revitalized interest in familiar letter vitamins

“Preventive healthcare products address­ing concerns like immunity are trending higher than symptomatic products; Mattern declares. “In this context, products with vita­mins C and D come to mind and benefit from decades of research and hundreds, if not thousands, of scientific publications backing their associated health claims.”

Maheshvari agrees. “Vitamin C has been scientifically proven as vital for immuni­ty.” he notes. “Strong published research also suggests that vitamin E is pivotal as an antioxidant in the immune response. It would appear from later research, too, that vitamin D and K levels are also important factors in how some respond to COVID, and how severely.”

Jia Zhang Lee, executive director, Davos Life Science (Singapore), notes that his com­pany has seen a steady increase in demand for vitamin E tocotrienols in particular. “Re­search studies have shown that tocotrienols have positive health benefits in the manage­ment of hypertension, heart disease, and di­abetes,” Lee notes. “These chronic conditions predispose individuals to the more severe form of COVID-19, and therefore there’s been growing interest in tocotrienol supplementa­tion to help promote the prevention of these chronic diseases.”

But plenty of botanicals, antioxidants, probiotics, and other more “exotic” nutrition­al ingredients have immune associations, too, so why have humble vitamins gotten so much glow?

For one, those “exotic” upstarts, Mattern argues, are “less understood by the wider population.”

Read full article